MAKv1 Exoskeleton for TKA Patients: a Safety, Usability and Clinical Effects Trial of an Early Intervention
NCT ID: NCT05544409
Last Updated: 2022-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2019-06-12
2021-02-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Total Versus Robotic Assisted Unicompartmental Knee Replacement
NCT05290818
Early Outcomes of MAKO Medial Unicompartmental Knee Arthroplasty
NCT05736601
MAKO Total Knee Artroplasty
NCT05744895
A Trial of Mechanical Axis With Soft Tissue Release Balancing vs Functional Alignment With Bony Release Balancing in Total Knee Replacement Using Stryker's Mako Robot
NCT04600583
A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot
NCT02650284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAKv1
The MAKv1 group will receive 1 hour of MAKv1 rehabilitation, thrice per week during 1 month
MAKv1
1 hour sessions with the MAKv1 exoskeleton, thrice per week during 1 month
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MAKv1
1 hour sessions with the MAKv1 exoskeleton, thrice per week during 1 month
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* postoperative complications that may be a risk to use the exoskeleton
* other conditions that prevented mobilisation in early stages after TKA
* weight \> 100 kg
* size \< 150 cm
* size \> 190 cm
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MarsiBionics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Luisa López Morón
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Sanitas La Zarzuela
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hozpital Universitario La Zarzuela
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TKA_MAK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.